Breaking the vicious cycle: How two German scientists seek to solve ME

Key Points:

• A "unifying hypothesis" for myalgic encephalomyelitis (ME) suggests the disease results from self-perpetuating mitochondrial damage in skeletal muscles caused by disrupted ion exchange, particularly calcium overload, triggered by factors like COVID-19.
• Researchers Klaus Wirth and Carmen Scheibenbogen have developed this comprehensive model linking ME symptoms, such as post-exertional malaise (PEM), to microcirculatory dysfunction, autoantibodies, and impaired muscle ion transport, with ongoing efforts to test a targeted drug compound, MDC 002.
• While the hypothesis is supported by some clinical and experimental data, key elements like calcium overload in patients remain unproven due to technical limitations, and the model may apply primarily to subsets of ME patients.
• Clinical trials focusing on immunoadsorption to remove autoantibodies show promising but preliminary results, with ongoing randomized controlled trials in Germany and the Netherlands aiming to clarify treatment efficacy and patient subgroups who benefit.
• Funding remains a critical barrier for advancing research and clinical trials, despite government support for post-infectious disease research, prompting patient advocates and researchers to call for increased urgency and investment in ME therapeutic development.